Filing Details

Accession Number:
0001209191-18-005568
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-26 16:18:26
Reporting Period:
2018-01-24
Accepted Time:
2018-01-26 16:18:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504597 Bosco Shin-Shing Chiu 800 W. Olympic Boulevard, Suite 406
Los Angeles CA 90015
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-24 1,000 $27.79 1,000 No 4 M Direct
Common Stock Disposition 2018-01-24 356 $78.21 644 No 4 D Direct
Common Stock Disposition 2018-01-24 223 $78.21 421 No 4 F Direct
Common Stock Acquisiton 2018-01-24 5,417 $53.29 5,838 No 4 M Direct
Common Stock Disposition 2018-01-24 3,691 $78.21 2,147 No 4 D Direct
Common Stock Disposition 2018-01-24 597 $78.21 1,550 No 4 F Direct
Common Stock Acquisiton 2018-01-24 2,561 $55.90 4,111 No 4 M Direct
Common Stock Disposition 2018-01-24 1,831 $78.21 2,280 No 4 D Direct
Common Stock Disposition 2018-01-24 253 $78.21 2,027 No 4 F Direct
Common Stock Acquisiton 2018-01-24 2,295 $44.79 4,322 No 4 M Direct
Common Stock Disposition 2018-01-24 1,315 $78.21 3,007 No 4 D Direct
Common Stock Disposition 2018-01-24 340 $78.21 2,667 No 4 F Direct
Common Stock Disposition 2018-01-26 2,667 $78.54 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-01-24 1,000 $0.00 1,000 $27.79
Common Stock Stock Appreciation Rights Disposition 2018-01-24 5,417 $0.00 5,417 $53.29
Common Stock Stock Appreciation Rights Disposition 2018-01-24 2,561 $0.00 2,561 $55.90
Common Stock Stock Appreciation Rights Disposition 2018-01-24 2,295 $0.00 2,295 $44.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-08-31 2020-08-31 No 4 M Direct
0 2014-05-18 2021-05-18 No 4 M Direct
0 2014-12-01 2021-12-01 No 4 M Direct
10,000 2015-05-31 2022-05-31 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2017.
  2. The reporting person received 421 shares of common stock upon the net exercise of 1,000 stock appreciation rights ("SARs"). The reporting person forfeited 356 shares of common stock underlying such SARS in payment of the exercise price and 223 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on January 24, 2018 of $78.21.
  3. The reporting person received 1,129 shares of common stock upon the net exercise of 5,417 SARs. The reporting person forfeited 3,691 shares of common stock underlying such SARS in payment of the exercise price and 597 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on January 24, 2018 of $78.21.
  4. The reporting person received 477 shares of common stock upon the net exercise of 2,561 SARs. The reporting person forfeited 1,831 shares of common stock underlying such SARS in payment of the exercise price and 253 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on January 24, 2018 of $78.21.
  5. The reporting person received 640 shares of common stock upon the net exercise of 2,295 SARs. The reporting person forfeited 1,315 shares of common stock underlying such SARS in payment of the exercise price and 340 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on January 24, 2018 of $78.21.